• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨肿瘤微环境中内皮细胞、免疫细胞和免疫检查点之间的串扰:新的见解和治疗意义。

Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications.

机构信息

Department of Breast Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 310003, Hangzhou, China.

Department of Breast and Thyroid Surgery, First Affiliated Hospital of Huzhou University, 313000, Huzhou, China.

出版信息

Cell Death Dis. 2023 Sep 4;14(9):586. doi: 10.1038/s41419-023-06119-x.

DOI:10.1038/s41419-023-06119-x
PMID:37666809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10477350/
Abstract

The tumor microenvironment (TME) is a highly intricate milieu, comprising a multitude of components, including immune cells and stromal cells, that exert a profound influence on tumor initiation and progression. Within the TME, angiogenesis is predominantly orchestrated by endothelial cells (ECs), which foster the proliferation and metastasis of malignant cells. The interplay between tumor and immune cells with ECs is complex and can either bolster or hinder the immune system. Thus, a comprehensive understanding of the intricate crosstalk between ECs and immune cells is essential to advance the development of immunotherapeutic interventions. Despite recent progress, the underlying molecular mechanisms that govern the interplay between ECs and immune cells remain elusive. Nevertheless, the immunomodulatory function of ECs has emerged as a pivotal determinant of the immune response. In light of this, the study of the relationship between ECs and immune checkpoints has garnered considerable attention in the field of immunotherapy. By targeting specific molecular pathways and signaling molecules associated with ECs in the TME, novel immunotherapeutic strategies may be devised to enhance the efficacy of current treatments. In this vein, we sought to elucidate the relationship between ECs, immune cells, and immune checkpoints in the TME, with the ultimate goal of identifying novel therapeutic targets and charting new avenues for immunotherapy.

摘要

肿瘤微环境(TME)是一个高度复杂的环境,包含多种成分,包括免疫细胞和基质细胞,它们对肿瘤的发生和发展有深远的影响。在 TME 中,血管生成主要由内皮细胞(ECs)协调,促进恶性细胞的增殖和转移。肿瘤细胞和免疫细胞与 ECs 之间的相互作用非常复杂,既可以增强也可以抑制免疫系统。因此,全面了解 ECs 和免疫细胞之间复杂的相互作用对于推进免疫治疗干预的发展至关重要。尽管最近取得了进展,但调控 ECs 和免疫细胞相互作用的潜在分子机制仍不清楚。然而,ECs 的免疫调节功能已成为免疫反应的关键决定因素。有鉴于此,研究 ECs 与免疫检查点之间的关系在免疫治疗领域引起了广泛关注。通过靶向 TME 中与 ECs 相关的特定分子途径和信号分子,可能会设计出新的免疫治疗策略来增强当前治疗的效果。在这方面,我们试图阐明 TME 中 ECs、免疫细胞和免疫检查点之间的关系,最终目的是确定新的治疗靶点,为免疫治疗开辟新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceba/10477350/47d0b98c1fd6/41419_2023_6119_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceba/10477350/268ee5452433/41419_2023_6119_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceba/10477350/1eae6dc7196e/41419_2023_6119_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceba/10477350/47d0b98c1fd6/41419_2023_6119_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceba/10477350/268ee5452433/41419_2023_6119_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceba/10477350/1eae6dc7196e/41419_2023_6119_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceba/10477350/47d0b98c1fd6/41419_2023_6119_Fig3_HTML.jpg

相似文献

1
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications.探讨肿瘤微环境中内皮细胞、免疫细胞和免疫检查点之间的串扰:新的见解和治疗意义。
Cell Death Dis. 2023 Sep 4;14(9):586. doi: 10.1038/s41419-023-06119-x.
2
Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.促甲状腺滤泡癌细胞间通讯中断可作为免疫治疗机会
Adv Exp Med Biol. 2021;1350:33-66. doi: 10.1007/978-3-030-83282-7_2.
3
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.探讨癌症干细胞与肿瘤微环境之间的动态相互作用:对新型治疗策略的启示。
J Transl Med. 2023 Oct 2;21(1):686. doi: 10.1186/s12967-023-04575-9.
4
Endothelial cells in tumor microenvironment: insights and perspectives.肿瘤微环境中的内皮细胞:深入了解和展望。
Front Immunol. 2024 Feb 15;15:1367875. doi: 10.3389/fimmu.2024.1367875. eCollection 2024.
5
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review.从神经胶质瘤的阴霾到免疫治疗的曙光:揭示新的免疫治疗范例——综述。
J Exp Clin Cancer Res. 2024 Feb 12;43(1):47. doi: 10.1186/s13046-024-02973-5.
6
Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies.肺癌炎性肿瘤微环境中的旁分泌调节与免疫系统通路:对肿瘤发生及免疫治疗策略的见解
Cancers (Basel). 2024 Mar 10;16(6):1113. doi: 10.3390/cancers16061113.
7
Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.内源性大麻素系统与肿瘤微环境:抗癌方法的新交织联系。
Cells. 2021 Dec 2;10(12):3396. doi: 10.3390/cells10123396.
8
Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy.肿瘤微环境中的新兴免疫检查点:对癌症免疫治疗的影响。
Cancer Lett. 2021 Jul 28;511:68-76. doi: 10.1016/j.canlet.2021.04.021. Epub 2021 May 3.
9
Wnt Signaling in the Tumor Microenvironment.肿瘤微环境中的 Wnt 信号通路。
Adv Exp Med Biol. 2021;1270:107-121. doi: 10.1007/978-3-030-47189-7_7.
10
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?间充质基质细胞(MSCs)与结直肠癌:抗肿瘤免疫反应中的一对麻烦搭档?
Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354.

引用本文的文献

1
The glioma microenvironment and its impact on antitumor immunity.胶质瘤微环境及其对抗肿瘤免疫的影响。
Neurooncol Adv. 2025 Sep 9;7(Suppl 4):iv19-iv31. doi: 10.1093/noajnl/vdae204. eCollection 2025 Sep.
2
Human cerebral organoids model tumor initiation and infiltration in an autologous astrocyte-supported setting.人脑类器官在自体星形胶质细胞支持的环境中模拟肿瘤起始和浸润。
iScience. 2025 Aug 11;28(9):113334. doi: 10.1016/j.isci.2025.113334. eCollection 2025 Sep 19.
3
Single-Cell Characterization of Anterior Segment Development: Cell Types, Pathways, and Signals Driving Formation of the Trabecular Meshwork and Schlemm's Canal.

本文引用的文献

1
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.派姆单抗联合卡博替尼治疗复发性转移性头颈部鳞状细胞癌:一项 2 期临床试验。
Nat Med. 2023 Apr;29(4):880-887. doi: 10.1038/s41591-023-02275-x. Epub 2023 Apr 3.
2
Blocking of programmed cell death-ligand 1 (PD-L1) expressed on endothelial cells promoted the recruitment of CD8IFN-γ T cells in atherosclerosis.阻断内皮细胞表达的程序性细胞死亡配体 1(PD-L1)可促进动脉粥样硬化中 CD8+IFN-γ T 细胞的募集。
Inflamm Res. 2023 Apr;72(4):783-796. doi: 10.1007/s00011-023-01703-5. Epub 2023 Mar 3.
3
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy.
眼前节发育的单细胞特征:驱动小梁网和施莱姆管形成的细胞类型、途径和信号
bioRxiv. 2025 Aug 21:2025.08.15.670438. doi: 10.1101/2025.08.15.670438.
4
From Microbial Switches to Metabolic Sensors: Rewiring the Gut-Brain Kynurenine Circuit.从微生物开关到代谢传感器:重新连接肠道-大脑犬尿氨酸回路
Biomedicines. 2025 Aug 19;13(8):2020. doi: 10.3390/biomedicines13082020.
5
Single-cell sequencing reveals the role of endothelial subsets in promoting early gastric cancer progression.单细胞测序揭示了内皮细胞亚群在促进早期胃癌进展中的作用。
Imeta. 2025 Jun 5;4(4):e70050. doi: 10.1002/imt2.70050. eCollection 2025 Aug.
6
Immune Evasion in Head and Neck Squamous Cell Carcinoma: Roles of Cancer-Associated Fibroblasts, Immune Checkpoints, and Mutations in the Tumor Microenvironment.头颈部鳞状细胞癌中的免疫逃逸:肿瘤相关成纤维细胞、免疫检查点及肿瘤微环境中突变的作用
Cancers (Basel). 2025 Aug 7;17(15):2590. doi: 10.3390/cancers17152590.
7
Small molecule intervention of actin-binding protein profilin1 reduces tumor angiogenesis in renal cell carcinoma.肌动蛋白结合蛋白原肌球蛋白1的小分子干预可减少肾细胞癌中的肿瘤血管生成。
bioRxiv. 2025 Jul 21:2025.07.18.665115. doi: 10.1101/2025.07.18.665115.
8
Development of tetraculture spheroids as a versatile 3D model for personalized breast cancer research.作为个性化乳腺癌研究通用三维模型的四元培养球体的开发。
Sci Rep. 2025 Jul 28;15(1):27449. doi: 10.1038/s41598-025-12556-9.
9
Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression.形态转变:内皮-间充质转化作为癌症进展的驱动因素
Int J Mol Sci. 2025 Jul 1;26(13):6353. doi: 10.3390/ijms26136353.
10
Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies.免疫肿瘤学处于十字路口:在寻求有效癌症疗法的过程中面临挑战。
Int J Mol Sci. 2025 Jun 26;26(13):6177. doi: 10.3390/ijms26136177.
全面分析 ICOS(CD278)在泛癌预后和免疫治疗中的作用。
BMC Cancer. 2023 Feb 28;23(1):194. doi: 10.1186/s12885-023-10564-4.
4
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.单药抗程序性死亡-1(MDX-1106)治疗难治性实体瘤的I期研究:安全性、临床活性、药效学及免疫相关性
J Clin Oncol. 2023 Feb 1;41(4):715-723. doi: 10.1200/JCO.22.02270.
5
The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy.VEGF/VEGFR 轴再探:对癌症治疗的影响。
Int J Mol Sci. 2022 Dec 9;23(24):15585. doi: 10.3390/ijms232415585.
6
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03).卡博替尼治疗既往接受过一种免疫检查点抑制剂治疗的晚期或不可切除肾细胞癌患者的多中心 2 期单臂研究:BREAKPOINT 试验(Meet-Uro 试验 03)。
Tumori. 2023 Feb;109(1):129-137. doi: 10.1177/03008916221138881. Epub 2022 Nov 29.
7
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.基于 CAR.CD123-NK 细胞的即用型免疫疗法治疗急性髓系白血病的安全性和有效性。
J Hematol Oncol. 2022 Nov 5;15(1):163. doi: 10.1186/s13045-022-01376-3.
8
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration.锌环二磷酸腺苷纳米颗粒通过内皮细胞中的干扰素基因刺激蛋白(STING)激活和肿瘤相关巨噬细胞的再激活来靶向并抑制肿瘤。
Nat Nanotechnol. 2022 Dec;17(12):1322-1331. doi: 10.1038/s41565-022-01225-x. Epub 2022 Oct 27.
9
The role of CCL2, CCL7, ICAM-1, and VCAM-1 in interaction of endothelial cells and natural killer cells.CCL2、CCL7、细胞间黏附分子-1(ICAM-1)和血管细胞黏附分子-1(VCAM-1)在内皮细胞与自然杀伤细胞相互作用中的作用。
Int Immunopharmacol. 2022 Dec;113(Pt A):109332. doi: 10.1016/j.intimp.2022.109332. Epub 2022 Oct 20.
10
Tumor buster - where will the CAR-T cell therapy 'missile' go?肿瘤克星——CAR-T 细胞疗法的“导弹”将飞向何方?
Mol Cancer. 2022 Oct 19;21(1):201. doi: 10.1186/s12943-022-01669-8.